The gut microbiota, bacterial metabolites and colorectal cancer.

PubWeight™: 2.55‹?› | Rank: Top 2%

🔗 View Article (PMID 25198138)

Published in Nat Rev Microbiol on September 08, 2014

Authors

Petra Louis1, Georgina L Hold2, Harry J Flint1

Author Affiliations

1: Microbiology Group, Rowett Institute of Nutrition and Health, University of Aberdeen, Greenburn Road, Bucksburn, Aberdeen AB21 9SB, UK.
2: Gastrointestinal Research Group, Division of Applied Medicine, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK.

Associated clinical trials:

Preventive Anti-inflammatory Diet to Reduce Gastro-intestinal Inflammation in FAP Patients: a Prospective Pilot Study (FAPPER) | NCT04552405

Articles citing this

(truncated to the top 100)

Taxonomer: an interactive metagenomics analysis portal for universal pathogen detection and host mRNA expression profiling. Genome Biol (2016) 1.99

The gut microbiota in conventional and serrated precursors of colorectal cancer. Microbiome (2016) 1.45

Unusual sub-genus associations of faecal Prevotella and Bacteroides with specific dietary patterns. Microbiome (2016) 1.44

Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health. Front Microbiol (2016) 1.20

Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut (2015) 1.17

Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol (2016) 1.14

Fusobacterium nucleatum and T Cells in Colorectal Carcinoma. JAMA Oncol (2015) 1.12

Gut microbiota-derived short-chain Fatty acids, T cells, and inflammation. Immune Netw (2014) 1.10

Emerging cytokine networks in colorectal cancer. Nat Rev Immunol (2015) 1.09

Cancer and the gut microbiota: an unexpected link. Sci Transl Med (2015) 1.08

Nutrients, foods, and colorectal cancer prevention. Gastroenterology (2015) 1.04

Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis. Cell Rep (2015) 1.03

Gut microbiota imbalance and colorectal cancer. World J Gastroenterol (2016) 0.99

The gastrointestinal microbiota and colorectal cancer. Am J Physiol Gastrointest Liver Physiol (2014) 0.94

Sialic acid catabolism drives intestinal inflammation and microbial dysbiosis in mice. Nat Commun (2015) 0.88

The Microbiota of Breast Tissue and Its Association with Breast Cancer. Appl Environ Microbiol (2016) 0.88

Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut. Front Microbiol (2016) 0.87

Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma. EBioMedicine (2016) 0.87

The environment of regulatory T cell biology: cytokines, metabolites, and the microbiome. Front Immunol (2015) 0.86

Transcriptional inhibition and mutagenesis induced by N-nitroso compound-derived carboxymethylated thymidine adducts in DNA. Nucleic Acids Res (2015) 0.86

Microbiome and cancer. Semin Immunopathol (2014) 0.85

Quantification of in Vivo Colonic Short Chain Fatty Acid Production from Inulin. Nutrients (2015) 0.85

Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD. Dig Dis Sci (2016) 0.84

Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab (2016) 0.83

Mutual Cross-Feeding Interactions between Bifidobacterium longum subsp. longum NCC2705 and Eubacterium rectale ATCC 33656 Explain the Bifidogenic and Butyrogenic Effects of Arabinoxylan Oligosaccharides. Appl Environ Microbiol (2015) 0.83

Synbiotic approach restores intestinal homeostasis and prolongs survival in leukaemic mice with cachexia. ISME J (2015) 0.83

Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human Health. Front Microbiol (2016) 0.83

The Common Gut Microbe Eubacterium hallii also Contributes to Intestinal Propionate Formation. Front Microbiol (2016) 0.83

Systems biology of host-microbe metabolomics. Wiley Interdiscip Rev Syst Biol Med (2015) 0.83

Women with preterm birth have a distinct cervicovaginal metabolome. Am J Obstet Gynecol (2015) 0.82

Biomarkers of Inflammation and Immune Function and Risk of Colorectal Cancer. Curr Colorectal Cancer Rep (2015) 0.82

Cancer Prevention: Obstacles, Challenges and the Road Ahead. J Natl Cancer Inst (2015) 0.82

Collateral damage: insights into bacterial mechanisms that predispose host cells to cancer. Nat Rev Microbiol (2017) 0.81

New paradigms in GPCR drug discovery. Biochem Pharmacol (2015) 0.81

Selective Manipulation of the Gut Microbiota Improves Immune Status in Vertebrates. Front Immunol (2015) 0.81

Robust bioengineered 3D functional human intestinal epithelium. Sci Rep (2015) 0.81

Chlorinated Water Modulates the Development of Colorectal Tumors with Chromosomal Instability and Gut Microbiota in Apc-Deficient Mice. PLoS One (2015) 0.81

Discordant temporal development of bacterial phyla and the emergence of core in the fecal microbiota of young children. ISME J (2015) 0.80

Production of butyrate from lysine and the Amadori product fructoselysine by a human gut commensal. Nat Commun (2015) 0.80

Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers. Int J Mol Sci (2016) 0.80

A metabolic perspective of Peto's paradox and cancer. Philos Trans R Soc Lond B Biol Sci (2015) 0.80

The Microbiome and Cancer: Is the 'Oncobiome' Mirage Real? Trends Cancer (2015) 0.80

Metabolic network rewiring of propionate flux compensates vitamin B12 deficiency in C. elegans. Elife (2016) 0.79

Individuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology. F1000Res (2015) 0.79

Luminal Conversion and Immunoregulation by Probiotics. Front Pharmacol (2015) 0.79

Chemical conversations in the gut microbiota. Gut Microbes (2016) 0.79

Interferon Tau Affects Mouse Intestinal Microbiota and Expression of IL-17. Mediators Inflamm (2016) 0.79

Untangling the fiber yarn: butyrate feeds Warburg to suppress colorectal cancer. Cancer Discov (2014) 0.79

Ability of the gut microbiota to produce PUFA-derived bacterial metabolites: Proof of concept in germ-free versus conventionalized mice. Mol Nutr Food Res (2015) 0.79

Cervical Microbiota Associated with Higher Grade Cervical Intraepithelial Neoplasia in Women Infected with High-Risk Human Papillomaviruses. Cancer Prev Res (Phila) (2016) 0.79

Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection. BMC Med (2016) 0.79

Interplay between diet, gut microbiota, epigenetic events, and colorectal cancer. Mol Nutr Food Res (2016) 0.79

Effect of Dietary Fibers on Cecal Microbiota and Intestinal Tumorigenesis in Azoxymethane Treated A/J Min/+ Mice. PLoS One (2016) 0.78

Development of a Bioluminescent Nitroreductase Probe for Preclinical Imaging. PLoS One (2015) 0.78

The metabolic fate of acetate in cancer. Nat Rev Cancer (2016) 0.78

Polysaccharide utilization loci and nutritional specialization in a dominant group of butyrate-producing human colonic Firmicutes. Microb Genom (2016) 0.78

Long noncoding RNA expression profiles in gut tissues constitute molecular signatures that reflect the types of microbes. Sci Rep (2015) 0.78

Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location. Clin Transl Gastroenterol (2016) 0.78

Antibiotic Treatment Affects Intestinal Permeability and Gut Microbial Composition in Wistar Rats Dependent on Antibiotic Class. PLoS One (2015) 0.78

Serum Endotoxins and Flagellin and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort. Cancer Epidemiol Biomarkers Prev (2016) 0.78

Slc10a2-null mice uncover colon cancer-promoting actions of endogenous fecal bile acids. Carcinogenesis (2015) 0.78

The Effect of Lactobacillus casei 32G on the Mouse Cecum Microbiota and Innate Immune Response Is Dose and Time Dependent. PLoS One (2015) 0.78

Metabolic and Community Synergy of Oral Bacteria in Colorectal Cancer. mSphere (2016) 0.78

Composition and function of the pediatric colonic mucosal microbiome in untreated patients with ulcerative colitis. Gut Microbes (2016) 0.77

Metabolism of Toxic Sugars by Strains of the Bee Gut Symbiont Gilliamella apicola. MBio (2016) 0.77

Sphingosine-1-phosphate in inflammatory bowel disease and colitis-associated colon cancer: the fat's in the fire. Transl Cancer Res (2015) 0.77

Bile acid: a potential inducer of colon cancer stem cells. Stem Cell Res Ther (2016) 0.77

Shifts in the fecal microbiota associated with adenomatous polyps. Cancer Epidemiol Biomarkers Prev (2016) 0.77

Metabolic modeling with Big Data and the gut microbiome. Appl Transl Genom (2016) 0.77

Moderate dietary protein restriction alters the composition of gut microbiota and improves ileal barrier function in adult pig model. Sci Rep (2017) 0.77

Sporadic colorectal cancer: microbial contributors to disease prevention, development and therapy. Br J Cancer (2016) 0.77

A Healthy Dietary Pattern Reduces Lung Cancer Risk: A Systematic Review and Meta-Analysis. Nutrients (2016) 0.77

The Role of the Microbiome in Gastrointestinal Cancer. Gastroenterol Clin North Am (2016) 0.77

Impact of the microbial derived short chain fatty acid propionate on host susceptibility to bacterial and fungal infections in vivo. Sci Rep (2016) 0.77

Toxic Markers of Matrine Determined Using (1) H-NMR-Based Metabolomics in Cultured Cells In Vitro and Rats In Vivo. Evid Based Complement Alternat Med (2015) 0.76

Role of the Aryl Hydrocarbon Receptor in Colon Neoplasia. Cancers (Basel) (2015) 0.76

Fucosyllactose and L-fucose utilization of infant Bifidobacterium longum and Bifidobacterium kashiwanohense. BMC Microbiol (2016) 0.76

Colorectal Cancer and the Human Gut Microbiome: Reproducibility with Whole-Genome Shotgun Sequencing. PLoS One (2016) 0.76

Biliary Microbiota, Gallstone Disease and Infection with Opisthorchis felineus. PLoS Negl Trop Dis (2016) 0.76

Acrolein contributes strongly to antimicrobial and heterocyclic amine transformation activities of reuterin. Sci Rep (2016) 0.76

Adenomatous polyposis coli genotype-dependent toll-like receptor 4 activity in colon cancer. Oncotarget (2016) 0.76

Sucralose administered in feed, beginning prenatally through lifespan, induces hematopoietic neoplasias in male swiss mice. Int J Occup Environ Health (2016) 0.76

Triterpenoid herbal saponins enhance beneficial bacteria, decrease sulfate-reducing bacteria, modulate inflammatory intestinal microenvironment and exert cancer preventive effects in ApcMin/+ mice. Oncotarget (2016) 0.76

The interplay of extracellular matrix and microbiome in urothelial bladder cancer. Nat Rev Urol (2015) 0.76

Liver Flukes and the Microbiota in Cancer. EBioMedicine (2016) 0.76

The microbial-mammalian metabolic axis: a critical symbiotic relationship. Curr Opin Clin Nutr Metab Care (2016) 0.75

Yacon (Smallanthus sonchifolius) as a Food Supplement: Health-Promoting Benefits of Fructooligosaccharides. Nutrients (2016) 0.75

Butyrate induces ROS-mediated apoptosis by modulating miR-22/SIRT-1 pathway in hepatic cancer cells. Redox Biol (2017) 0.75

Wheat bran promotes enrichment within the human colonic microbiota of butyrate-producing bacteria that release ferulic acid. Environ Microbiol (2016) 0.75

Sensitive and Simplified Detection of Antibiotic Influence on the Dynamic and Versatile Changes of Fecal Short-Chain Fatty Acids. PLoS One (2016) 0.75

Dietary Keratan Sulfate from Shark Cartilage Modulates Gut Microbiota and Increases the Abundance of Lactobacillus spp. Mar Drugs (2016) 0.75

Effects of Dietary Fibre (Pectin) and/or Increased Protein (Casein or Pea) on Satiety, Body Weight, Adiposity and Caecal Fermentation in High Fat Diet-Induced Obese Rats. PLoS One (2016) 0.75

The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions. Therap Adv Gastroenterol (2016) 0.75

Dietary grape seed proanthocyanidins (GSPs) improve weaned intestinal microbiota and mucosal barrier using a piglet model. Oncotarget (2016) 0.75

Bile acids destabilise HIF-1α and promote anti-tumour phenotypes in cancer cell models. BMC Cancer (2016) 0.75

Elucidation of the Mechanisms through Which the Reactive Metabolite Diclofenac Acyl Glucuronide Can Mediate Toxicity. J Pharmacol Exp Ther (2016) 0.75

Sasa quelpaertensis leaf extract regulates microbial dysbiosis by modulating the composition and diversity of the microbiota in dextran sulfate sodium-induced colitis mice. BMC Complement Altern Med (2016) 0.75

Extending colonic mucosal microbiome analysis-assessment of colonic lavage as a proxy for endoscopic colonic biopsies. Microbiome (2016) 0.75

The Microbiome and Sustainable Healthcare. Healthcare (Basel) (2015) 0.75

An ornamental plant targets epigenetic signaling to block cancer stem cell-driven colon carcinogenesis. Carcinogenesis (2016) 0.75